ICCM vs. DRIO, AMIX, APYX, NSPR, LUCD, LNSR, CTSO, DXR, HSAQ, and CTCX
Should you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include DarioHealth (DRIO), Autonomix Medical (AMIX), Apyx Medical (APYX), InspireMD (NSPR), Lucid Diagnostics (LUCD), LENSAR (LNSR), Cytosorbents (CTSO), Daxor (DXR), Health Sciences Acquisitions Co. 2 (HSAQ), and Carmell (CTCX). These companies are all part of the "surgical & medical instruments" industry.
IceCure Medical (NASDAQ:ICCM) and DarioHealth (NASDAQ:DRIO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, risk, institutional ownership, valuation, dividends, media sentiment, community ranking and earnings.
IceCure Medical has a beta of 0.7, indicating that its share price is 30% less volatile than the S&P 500. Comparatively, DarioHealth has a beta of 1.64, indicating that its share price is 64% more volatile than the S&P 500.
DarioHealth has a net margin of -282.38% compared to IceCure Medical's net margin of -453.76%. DarioHealth's return on equity of -76.11% beat IceCure Medical's return on equity.
IceCure Medical currently has a consensus target price of $2.95, suggesting a potential upside of 180.93%. DarioHealth has a consensus target price of $4.05, suggesting a potential upside of 130.11%. Given IceCure Medical's higher probable upside, research analysts plainly believe IceCure Medical is more favorable than DarioHealth.
IceCure Medical has higher earnings, but lower revenue than DarioHealth. IceCure Medical is trading at a lower price-to-earnings ratio than DarioHealth, indicating that it is currently the more affordable of the two stocks.
0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 33.4% of DarioHealth shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 15.7% of DarioHealth shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, DarioHealth had 5 more articles in the media than IceCure Medical. MarketBeat recorded 8 mentions for DarioHealth and 3 mentions for IceCure Medical. DarioHealth's average media sentiment score of 0.39 beat IceCure Medical's score of 0.03 indicating that DarioHealth is being referred to more favorably in the news media.
DarioHealth received 221 more outperform votes than IceCure Medical when rated by MarketBeat users. However, 94.44% of users gave IceCure Medical an outperform vote while only 67.04% of users gave DarioHealth an outperform vote.
Summary
DarioHealth beats IceCure Medical on 11 of the 16 factors compared between the two stocks.
Get IceCure Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ICCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
IceCure Medical Competitors List
Related Companies and Tools
